Sleep Medicine News

As of Dec. 1, the FDA had approved 46 novel drugs this year, one fewer than it had approved by the same date in 2020.

Healio’s coverage of sleep studies throughout the year highlight the importance of a good night’s rest.

Cognitive behavioral therapy for insomnia may help prevent major depression among older adults with insomnia disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.

Presence of obstructive sleep apnea or CPAP use did not impact weight or glycemic outcomes at 2 months among adults with class 3 obesity, according to new research published in BMC Endocrine Disorders.

The AAP has partnered with five hospitals on a new, multi-year initiative meant to assist parents in creating safe sleeping environments for their infants.

Sleep-related hypoxia may be a risk factor for detrimental COVID-19 outcomes, according to results of a case-control study published in JAMA Network Open.

Older adults frequently used medication to treat sleep difficulties, according to study results presented at Psych Congress.

Preoperative presence of REM sleep behavior disorder in patients with Parkinson’s disease did not correlate with different clinical outcome 1 year after subthalamic deep brain stimulation, according to a study published in Neurology.

LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.

In patients with moderate to severe obstructive sleep apnea, carbonic anhydrase inhibition with sulthiame was safe and improved outcomes in the short term, researchers reported at the European Respiratory Society International Congress.